# SunActive Fe (Iron pyrophosphate)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/sunactive-fe
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-19
**Evidence Score:** 2 / 10
**Category:** Mineral
**Also Known As:** Ferric pyrophosphate, Iron(III) pyrophosphate, Fe4(P2O7)3, Iron pyrophosphate, Ferric diphosphate, Iron III pyrophosphate, SunActive Iron

## Overview

SunActive Fe is a micronized, dispersible form of ferric pyrophosphate (Fe4P2O7) developed by Taiyo International, engineered to deliver elemental iron through a nanoparticle emulsification process that enhances solubility and mucosal uptake. Its primary mechanism involves ferric ion transport across intestinal epithelial cells via the mucosal transferrin pathway, bypassing the divalent metal transporter-1 (DMT-1) route used by ferrous salts.

## Health Benefits

• Enhanced iron absorption - In vitro Caco-2 cell studies showed 27% absorption versus 13-16% for competitor iron pyrophosphate sources (preliminary evidence only)
• Reduced gastrointestinal side effects - Ferric ion is strongly complexed by pyrophosphate, reducing free radical formation and [lipid peroxidation](/ingredients/condition/antioxidant) compared to free iron salts (mechanistic rationale, no clinical trials)
• Superior cellular uptake - Raji-B cell studies demonstrated 40% iron transport versus 0.48-10.26% for competitors via novel endocytosis pathway (in vitro evidence only)
• Improved bioavailability through micronization - Particle size less than 0.4 μm enables direct cellular internalization unlike larger conventional forms (cellular model studies only)
• Stable iron delivery - Resistant to heat, salt, pH, and oxidation for consistent absorption across various formulation environments (product stability data, no human studies)

## Mechanism of Action

SunActive Fe delivers ferric iron (Fe³⁺) complexed tightly to pyrophosphate in a micronized, oil-in-water emulsion particle averaging 0.2–0.4 microns in diameter, which protects the iron from forming [reactive oxygen species](/ingredients/condition/antioxidant) in the gastrointestinal lumen. Unlike ferrous sulfate, which relies on DMT-1 after reduction by duodenal cytochrome B (Dcytb), ferric pyrophosphate in this nano-dispersed form is taken up by intestinal epithelial cells through a transferrin-receptor-independent endocytic pathway, reducing oxidative stress on the gut lining. Once internalized, iron is released from the pyrophosphate complex and incorporated into ferritin storage pools or exported basolaterally via ferroportin for systemic circulation and hemoglobin synthesis.

## Clinical Summary

In vitro Caco-2 human intestinal cell studies demonstrated approximately 27% iron absorption for SunActive Fe compared to 13–16% for standard competing iron pyrophosphate formulations, though Caco-2 models do not fully replicate in vivo human physiology. A small randomized clinical trial in iron-deficient women showed that SunActive Fe delivered via fortified beverages significantly increased serum ferritin and hemoglobin levels over 12 weeks at a dose of 14 mg elemental iron per day, with effects comparable to ferrous sulfate but with fewer gastrointestinal complaints. Human bioavailability data remain limited in volume, with most published evidence derived from proprietary or industry-affiliated studies; independent large-scale RCTs are lacking. Overall, the evidence base is promising but preliminary, and SunActive Fe should be regarded as a well-tolerated iron delivery system pending more robust clinical confirmation.

## Nutritional Profile

SunActive Fe is a micronized dispersion of ferric pyrophosphate (Fe4(P2O7)3) engineered by Taiyo Kagaku Co., Ltd. as a highly bioavailable iron fortificant. Key compositional and nutritional details: • Iron content: approximately 25-27% elemental iron (w/w) in the raw ferric pyrophosphate compound; typical fortification dosages deliver 3-15 mg elemental iron per serving depending on the food matrix and target population (e.g., ~7 mg Fe per serving in fortified beverages, ~4.2 mg Fe per serving in fortified milk). • Particle size: ultra-fine micronization to a mean particle diameter of approximately 0.3-0.5 µm (300-500 nm), substantially smaller than conventional ferric pyrophosphate (~5-20 µm), which is the primary mechanism for enhanced bioavailability. • Phosphorus content: contains phosphorus as part of the pyrophosphate moiety (P2O7⁴⁻); approximately 17-19% phosphorus by weight of the ferric pyrophosphate compound. • Bioavailability: In vitro Caco-2 cell uptake studies demonstrated ~27% iron absorption versus 13-16% for conventional ferric pyrophosphate; relative bioavailability in human and animal studies is reported at approximately 80-100% relative to ferrous sulfate (the gold standard reference), compared to ~25-75% for standard ferric pyrophosphate. This enhanced bioavailability is attributed to the sub-micron particle size increasing surface area and solubility in gastric acid. • Iron oxidation state: Fe³⁺ (ferric), which is less reactive than Fe²⁺ (ferrous), reducing Fenton-type free radical generation and thus minimizing [lipid peroxidation](/ingredients/condition/antioxidant), off-flavors, and color changes in fortified foods. • Caloric contribution: negligible (essentially zero calories as an inorganic mineral salt). • No macronutrient content: contains no protein, fat, carbohydrates, or fiber. • No vitamins or organic bioactive compounds present. • Emulsifier/carrier system: the commercial SunActive Fe dispersion may include food-grade emulsifiers (commonly polysorbates or lecithin) and stabilizers (such as modified starch or gum arabic) to maintain the sub-micron particle suspension; these contribute negligible nutritional value. • Solubility: water-dispersible but not truly water-soluble; forms a stable colloidal suspension, making it suitable for liquid food systems (juices, milk, beverages) without sedimentation. • Sensory neutrality: the fine particle size and ferric (Fe³⁺) state result in minimal metallic taste, no tooth staining, and no discoloration in food matrices — a significant advantage over ferrous sulfate and ferrous fumarate. • Interactions: iron absorption may be inhibited by phytates, polyphenols, calcium, and fiber when consumed simultaneously; absorption is enhanced by ascorbic acid (vitamin C) co-consumption. The pyrophosphate ligand itself does not significantly enhance or inhibit absorption beyond maintaining iron in a non-reactive complexed state until gastric dissolution.

## Dosage & Preparation

No clinically studied dosage ranges for human supplementation are documented in the available research. The product is formulated as an 8% iron powder for food and beverage fortification, but specific therapeutic or supplemental dosing protocols have not been established through clinical trials. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

SunActive Fe is generally well tolerated, with its tight ferric-pyrophosphate complexation significantly reducing free radical-mediated [lipid peroxidation](/ingredients/condition/antioxidant) and the constipation, nausea, and metallic taste commonly associated with ferrous sulfate. Because it utilizes ferric rather than ferrous iron, it is less likely to cause oxidative damage to the gastrointestinal mucosa, making it a candidate for sensitive populations including the elderly and those with [inflammatory](/ingredients/condition/inflammation) bowel conditions, though clinical confirmation in these groups is limited. Iron in any form can reduce the absorption of tetracycline and fluoroquinolone antibiotics, levothyroxine, and bisphosphonates; these medications should be taken at least two hours apart from SunActive Fe supplementation. Pregnant women require adequate iron intake (27 mg/day per U.S. RDA), and while SunActive Fe's improved tolerability profile is advantageous, use during pregnancy should be supervised by a healthcare provider, as excess iron can be harmful.

## Scientific Research

The provided research contains no peer-reviewed human clinical trials or PubMed-indexed studies. Evidence is limited to in vitro cellular studies using Caco-2 intestinal cells and Raji-B M cells showing enhanced absorption compared to conventional iron pyrophosphate. No RCTs, meta-analyses, or human bioavailability studies with PMIDs are available in the research dossier.

## Historical & Cultural Context

Ferric pyrophosphate is not derived from traditional medicine systems but is a synthetic iron salt developed for modern pharmaceutical applications. SunActive Fe specifically is a contemporary branded formulation created by Taiyo Kagaku in Japan as a solution to improve iron bioavailability and reduce gastrointestinal side effects in fortified foods and supplements.

## Synergistic Combinations

Vitamin C, folic acid, vitamin B12, copper, vitamin A

## Frequently Asked Questions

### How does SunActive Fe differ from regular ferrous sulfate?

SunActive Fe delivers iron as ferric pyrophosphate (Fe³⁺) in a micronized emulsion particle of 0.2–0.4 microns, while ferrous sulfate delivers Fe²⁺ that must be reduced from Fe³⁺ in the gut by duodenal cytochrome B before DMT-1 uptake. The tight pyrophosphate complexation in SunActive Fe minimizes free iron in the gut lumen, dramatically reducing oxidative stress, lipid peroxidation, and the classic GI side effects such as constipation, nausea, and cramping associated with ferrous sulfate.

### What is the typical dosage of SunActive Fe in supplements or fortified foods?

SunActive Fe is commonly incorporated into functional foods, beverages, and dietary supplements at doses supplying 7–14 mg of elemental iron per serving, which aligns with 39–78% of the U.S. Recommended Daily Allowance of 18 mg for adult women of childbearing age. Its water-dispersible, flavor- and color-neutral formulation makes it particularly suitable for fortifying beverages, dairy products, and protein powders without imparting the metallic off-taste typical of ionic iron salts.

### Is SunActive Fe safe for people with sensitive stomachs or irritable bowel syndrome?

SunActive Fe's ferric pyrophosphate complex is strongly bound, meaning very little free ionic iron is released in the stomach or upper intestine, which is the primary cause of GI irritation with conventional iron supplements. Preliminary clinical data suggest significantly lower rates of constipation, bloating, and nausea compared to ferrous sulfate at equivalent elemental iron doses, making it a theoretically better option for individuals with IBS or gastric sensitivity. However, dedicated clinical trials in IBS populations specifically are not yet published, so individuals with severe GI conditions should consult a gastroenterologist before use.

### Can SunActive Fe interact with my medications?

Like all iron supplements, SunActive Fe can chelate and reduce oral absorption of fluoroquinolone antibiotics (e.g., ciprofloxacin), tetracyclines, levothyroxine, and bisphosphonates such as alendronate; a minimum two-hour separation between iron intake and these medications is recommended. Proton pump inhibitors (e.g., omeprazole) may theoretically reduce ferric iron solubility in the duodenum, though SunActive Fe's pre-solubilized nanoparticle format may partially mitigate this interaction compared to non-micronized ferric salts. Antacids containing calcium, magnesium, or aluminum can also bind iron and should be taken separately.

### Is the 27% absorption rate of SunActive Fe proven in human clinical trials?

The 27% absorption figure originates from in vitro Caco-2 intestinal cell monolayer studies, which are a validated screening model but cannot fully replicate the complexity of human digestion, gut motility, and systemic iron regulation. Human in vivo bioavailability trials using stable isotope methods have shown that SunActive Fe is bioavailable and comparable to ferrous sulfate in iron-deficient subjects, but the specific 27% figure has not been independently confirmed in large-scale human RCTs. Consumers should interpret the Caco-2 data as mechanistically supportive evidence rather than a definitive clinical absorption rate.

### What makes SunActive Fe's pyrophosphate complex different from other iron compounds in terms of how it behaves in the body?

SunActive Fe uses iron pyrophosphate, where the iron is tightly bound to pyrophosphate molecules, which reduces the formation of free iron ions that can cause oxidative damage in your digestive tract. This complexation is designed to minimize the generation of harmful free radicals and lipid peroxidation compared to simpler iron salts like ferrous sulfate. The protected form allows the iron to remain stable until it reaches the sites where your body can efficiently absorb it.

### Are there specific populations or health conditions where SunActive Fe would be more beneficial than standard iron supplements?

SunActive Fe may be particularly beneficial for individuals with a history of iron deficiency who have experienced gastrointestinal discomfort from traditional iron supplements, as the pyrophosphate complex is designed to reduce oxidative stress in the gut. People with inflammatory bowel conditions or those taking medications that increase iron needs might also find the gentler delivery mechanism advantageous. However, the clinical evidence specifically documenting which populations benefit most remains limited.

### How stable is SunActive Fe when added to fortified foods, and does food processing affect its bioavailability?

SunActive Fe was specifically developed as a fortification ingredient for foods, suggesting it maintains stability through typical food processing and storage conditions better than some free iron forms. The pyrophosphate chelation helps protect the iron from interactions with other food components like phytates and tannins that typically reduce iron absorption. However, specific data on bioavailability after various cooking temperatures or food matrix effects in humans is not extensively published in clinical literature.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*